AAAAAA

   
Results: 1-14 |
Results: 14

Authors: LEA AP LAMB HM
Citation: Ap. Lea et Hm. Lamb, AZITHROMYCIN - A PHARMACOECONOMIC REVIEW OF ITS USE AS A SINGLE-DOSE REGIMEN IN THE TREATMENT OF UNCOMPLICATED UROGENITAL CLAMYDIA-TRACHOMATIS INFECTIONS IN WOMEN. (VOL 12, PG 596, 1997), PharmacoEconomics, 13(6), 1998, pp. 696-696

Authors: LEA AP BALFOUR JA
Citation: Ap. Lea et Ja. Balfour, VIROSOMAL HEPATITIS-A VACCINE (STRAIN RG-SB) - A PRELIMINARY REVIEW OF ITS IMMUNOGENICITY, PROTECTIVE EFFICACY AND TOLERABILITY IN AT-RISK POPULATIONS, Biodrugs, 7(3), 1997, pp. 232-248

Authors: LEA AP LAMB HM
Citation: Ap. Lea et Hm. Lamb, AZITHROMYCIN - A PHARMACOECONOMIC REVIEW OF ITS USE AS A SINGLE-DOSE REGIMEN IN THE TREATMENT OF UNCOMPLICATED UROGENITAL CHLAMYDIA-TRACHOMATIS INFECTIONS IN WOMEN, PharmacoEconomics, 12(5), 1997, pp. 596-615

Authors: DUNN CJ LEA AP WAGSTAFF AJ
Citation: Cj. Dunn et al., CARVEDILOL - A REAPPRAISAL OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN CARDIOVASCULAR DISORDERS, Drugs, 54(1), 1997, pp. 161-185

Authors: LEA AP MCTAVISH D
Citation: Ap. Lea et D. Mctavish, ATORVASTATIN - A REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC POTENTIALIN THE MANAGEMENT OF HYPERLIPIDEMIAS, Drugs, 53(5), 1997, pp. 828-847

Authors: LEA AP GOA KL
Citation: Ap. Lea et Kl. Goa, PIRAZOLAC, CLINICAL IMMUNOTHERAPEUTICS, 6(6), 1996, pp. 506-510

Authors: LEA AP GOA KL
Citation: Ap. Lea et Kl. Goa, COPOLYMER-1 - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC POTENTIAL IN MULTIPLE-SCLEROSIS, CLINICAL IMMUNOTHERAPEUTICS, 6(4), 1996, pp. 319-331

Authors: LEA AP GOA KL
Citation: Ap. Lea et Kl. Goa, CALCIPOTRIOL - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN THE MANAGEMENT OF PSORIASIS, CLINICAL IMMUNOTHERAPEUTICS, 5(3), 1996, pp. 230-248

Authors: LEA AP BRYSON HM BALFOUR JA
Citation: Ap. Lea et al., POTENTIALLY SERIOUS ADVERSE EVENTS SUCH AS PRIAPISM (GREATER-THAN-6 HOURS DURATION) AND FIBROSIS OCCURRED IN 0.4 AND 8-PERCENT OF PATIENTS (VOL 8, PG 57, 1996), Drugs & aging, 8(5), 1996, pp. 357-357

Authors: LEA AP BRYSON HM BALFOUR JA
Citation: Ap. Lea et al., INTRACAVERNOUS ALPROSTADIL - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND THERAPEUTIC POTENTIAL IN ERECTILE DYSFUNCTION, Drugs & aging, 8(1), 1996, pp. 56-74

Authors: LEA AP FAULDS D
Citation: Ap. Lea et D. Faulds, RITONAVIR, Drugs, 52(4), 1996, pp. 541-546

Authors: LEA AP BRYSON HM
Citation: Ap. Lea et Hm. Bryson, CIDOFOVIR, Drugs, 52(2), 1996, pp. 225-230

Authors: LEA AP FAULDS D
Citation: Ap. Lea et D. Faulds, STAVUDINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND CLINICAL POTENTIAL IN HIV-INFECTION, Drugs, 51(5), 1996, pp. 846-864

Authors: LEA AP SUMMERFIELD Q
Citation: Ap. Lea et Q. Summerfield, MINIMAL SPECTRAL CONTRAST OF FORMANT PEAKS FOR VOWEL RECOGNITION AS AFUNCTION OF SPECTRAL SLOPE, Perception & psychophysics, 56(4), 1994, pp. 379-391
Risultati: 1-14 |